Intensive Ambulance-delivered Blood Pressure Reduction in Hyper-Acute Stroke Trial
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 2000
Summary
- Conditions
- Cerebrovascular Disorders
- Stroke Acute
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: central randomization with stratificationMasking: Single (Outcomes Assessor)Masking Description: Outcome assessor is independent of the treatment teamPrimary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
As an investigator initiated and conducted, multicentre, ambulance-delivered, prospective, randomised, open-label, blinded outcome (PROBE) study. INTERACT4 aims to evaluate the effects of functional outcome according to an ordinal analysis of the full range of scores on the mRS, the safety in all ra...
As an investigator initiated and conducted, multicentre, ambulance-delivered, prospective, randomised, open-label, blinded outcome (PROBE) study. INTERACT4 aims to evaluate the effects of functional outcome according to an ordinal analysis of the full range of scores on the mRS, the safety in all randomised patients; reperfusion treatment (thrombolysis and/or thrombectomy) related symptomatic ICH (sICH, according to standard definitions), infarct size, the time to and overall rate of reperfusion treatment in AIS patients; hematoma volume and early expansion in ICH.
Tracking Information
- NCT #
- NCT03790800
- Collaborators
- Shanghai East Hospital
- First Affiliated Hospital of Chengdu Medical College
- Investigators
- Principal Investigator: Craig Anderson The George Institute for Global Health, China Principal Investigator: Gang Li Shanghai East Hospital Principal Investigator: Jie Yang The First Affliated Hospital of Chengdu Medical College
Get Well Soon